Skip to main content
. 2023 Jun 29;11(6):e005584. doi: 10.1136/jitc-2022-005584

Figure 3.

Figure 3

Tumor burden change from baseline in solid tumor patients (A, B) and lymphoma patients (C, D). In A, C, color indicates dose level as denoted in the inset. In B, D, color (inset) denotes tumor response by RECIST criteria for patients with solid tumors and Lugano criteria for patients with lymphoma. RECIST, Response Evaluation Criteria in Solid Tumors.